Regulus Therapeutics
RGLS
#9395
Rank
NZ$0.11 B
Marketcap
$1.77
Share price
0.00%
Change (1 day)
-19.85%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -NZ$66.79 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$52.21 Million a decrease over its 2022 earnings that were of -NZ$49.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$66.79 Million27.93%
2023 -NZ$52.21 Million6.51%
2022 -NZ$49.02 Million2.53%
2021 -NZ$47.81 Million93.59%
2020 -NZ$24.7 Million-15.41%
2019 -NZ$29.2 Million-64.46%
2018 -NZ$82.13 Million-33.26%
2017 -NZ$0.13 Billion-13.98%
2016 -NZ$0.15 Billion44.77%
2015 -NZ$98.83 Million-1.63%
2014 -NZ$0.11 Billion203.6%
2013 -NZ$33.1 Million8.65%
2012 -NZ$30.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.39 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$13.13 B-18,006.74%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$3.38 B-4,707.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.10 B-23,409.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.34 Billion 351.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.21 Billion 16,530.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA